Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time.
Milestone Pharmaceuticals' mailing address is 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420, MONTREAL A8, H4M 2X6. Learn about financial terms, types of investments, trading strategies and more.
MONTREAL and CHARLOTTE, N.C., Oct. 23, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today announced the pricing of its previously announced underwritten public offering of 3,810,097 of its … Fundamental company data provided by Morningstar and Zacks Investment Research.
There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Milestone Pharmaceuticals' stock is owned by a variety of retail and institutional investors. 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Milestone Pharmaceuticals in the last year. View Milestone Pharmaceuticals' earnings history. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Get daily stock ideas top-performing Wall Street analysts. Milestone Pharmaceuticals has a P/B Ratio of 1.37. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Source: FactSet. Learn more. Only 4.16% of the stock of Milestone Pharmaceuticals is held by insiders. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services.
Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. (Add your “underperform” vote.).
Milestone Pharmaceuticals' stock was trading at $5.80 on November 3rd, 2020 when U.S. federal elections occured and Joe Biden was elected president. Top institutional investors include California Public Employees Retirement System (0.21%) and State Street Corp (0.07%).
Learn more. One share of MIST stock can currently be purchased for approximately $6.43. 4 brokerages have issued 1 year target prices for Milestone Pharmaceuticals' stock. Jefferies, Cowen and Piper Jaffray served as the underwriters for the IPO and Oppenheimer & Co. was co-manager.
Milestone Pharmaceuticals has a market capitalization of $158.89 million.
Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock.
View institutional ownership trends for Milestone Pharmaceuticals. Milestone Pharmaceuticals has received no research coverage in the past 90 days. International stock quotes are delayed as per exchange requirements. MIST is not currently paying a regular dividend. (MIST) raised $75 million in an initial public offering on Thursday, May 9th 2019. Milestone Pharmaceuticals saw a drop in short interest in the month of September. View which stocks have been most impacted by the election. Milestone Pharmaceuticals has received 53.04% “outperform” votes from our community. Their forecasts range from $8.00 to $18.00.
To see all exchange delays and terms of use please see disclaimer. This suggests a possible upside of 106.1% from the stock's current price.
Milestone Pharmaceuticals operates in Canada and the United States. You may vote once every thirty days. Change value during other periods is calculated as the difference between the last trade and the most recent settle. マネーフォワード クラウド会計なら複雑な集計は不要！自動で予測給付額を把握できる。.
In the past three months, Milestone Pharmaceuticals insiders have not sold or bought any company stock.
For more information, visit www.milestonepharma.com and follow the Company on Twitter at @MilestonePharma.
The company can be reached via phone at 514-336-0444 or via email at [email protected].
Milestone Pharmaceuticals (MIST) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. The company reported ($0.53) earnings per share for the quarter, missing analysts' consensus estimates of ($0.51) by $0.02. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data.
Data may be intentionally delayed pursuant to supplier requirements. Source: Kantar Media. View insider buying and selling activity for Milestone Pharmaceuticals. Every investor in Milestone Pharmaceuticals Inc. (NASDAQ:MIST) should be aware of the most powerful shareholder... Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Receive a free world-class investing education from MarketBeat. Sign-up to receive the latest news and ratings for MIST and its competitors with MarketBeat's FREE daily newsletter. According to analysts' consensus price target of $13.25, Milestone Pharmaceuticals has a forecasted upside of 106.1% from its current price of $6.43. Since then, MIST stock has decreased by 67.8% and is now trading at $6.43. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. View which stocks have been most impacted by COVID-19.
Please log in to your account or sign up in order to add this asset to your watchlist. Vote “Outperform” if you believe MIST will outperform the S&P 500 over the long term. Milestone Pharmaceuticals Inc. (NASDAQ:MIST) posted its quarterly earnings data on Wednesday, August, 12th. Milestone Pharmaceuticals' management team includes the following people: Start Your Risk-Free Trial Subscription Here, Datadog (NASDAQ:DDOG) Is Coming Back To Earth, Get Ready To Buy Some, 3 Restaurant Stocks Delivering Strong Results, Advance Auto Parts (NYSE:AAP) Growth Accelerates, Shares Fall, Pared Down WarnerMedia Makes AT&T (NYSE:T) Look a Bit More Attractive, Campbell (NYSE: CPB) Stock is a Seasonal Buy Wrapped in Stockpiling Rollback Potential, It’s Time To Lighten Up On Rockwell Automation (NYSE:ROK), Ulta Beauty (NASDAQ:ULTA): A Retail Stock Worth Watching, 3 Stocks to Buy that Can Benefit from the Vaccine News, Workhorse Group (NASDAQ:WKHS) Is The Next EV Stock You Need To Buy, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, 8 Stocks That Robinhood Investors Got Right, 7 Stocks That Will Help You Forget About the Fed, Receive Analysts' Upgrades and Downgrades Daily.
It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for the treatment of atrial fibrillation, angina, and other cardiovascular indications. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. See what's happening in the market right now with MarketBeat's real-time news feed.
Milestone Pharmaceuticals does not currently pay a dividend. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings. Get short term trading ideas from the MarketBeat Idea Engine. As of September 30th, there was short interest totaling 464,100 shares, a drop of 17.7% from the September 15th total of 563,700 shares. Some companies that are related to Milestone Pharmaceuticals include Emisphere Technologies (EMIS), Omeros (OMER), Kadmon (KDMN), Kadmon (KDMN), Geron (GERN), Flexion Therapeutics (FLXN), Spectrum Pharmaceuticals (SPPI), VBI Vaccines (VBIV), Basilea Pharmaceutica (BPMUF), XBiotech (XBIT), ZIOPHARM Oncology (ZIOP), IVERIC bio (ISEE), SIGA Technologies (SIGA), Silence Therapeutics (SLN) and Graybug Vision (GRAY). View which stocks have been most impacted by COVID-19. Shares of MIST can be purchased through any online brokerage account. MIST stock was bought by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, and State Street Corp. Company insiders that have bought Milestone Pharmaceuticals stock in the last two years include Holdings A/S Novo, Rtw Investments, Lp, and Stonepine Capital, LP. Vote “Underperform” if you believe MIST will underperform the S&P 500 over the long term. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.
Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Milestone Pharmaceuticals' stock was trading at $19.99 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO).
© American Consumer News, LLC dba MarketBeat® 2010-2020. Since then, MIST stock has increased by 10.9% and is now trading at $6.43. © 2020 Verizon Media. Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Pharmaceuticals investors own include Sorrento Therapeutics (SRNE), VBI Vaccines (VBIV), CymaBay Therapeutics (CBAY), Ibio (IBIO), Allena Pharmaceuticals (ALNA), Fulcrum Therapeutics (FULC), OPKO Health (OPK), VYNE Therapeutics (VYNE), Soleno Therapeutics (SLNO) and Agile Therapeutics (AGRX). 39.42% of the stock of Milestone Pharmaceuticals is held by institutions. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. All rights reserved. Copyright 2019© FactSet Research Systems Inc. All rights reserved.
View Milestone Pharmaceuticals' Short Interest. All rights reserved. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Fundamental company data and analyst estimates provided by FactSet.
326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257
The official website for Milestone Pharmaceuticals is www.milestonepharma.com. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. View the latest Milestone Pharmaceuticals Inc. (MIST) stock price, news, historical charts, analyst ratings and financial information from WSJ.
How Many Planes Landed In Gander On 9/11, Overlocker Problem Solving, French Movies 2017, Crab Claws Fried, Lincoln Parish Sales Tax, Roma Nun Fa' La Stupida Stasera Autore, Coconut And Mango Intercropping, Alabama Primary Senate, Tips For Making And Keeping Friends, Ac Odyssey Neema Romance, 2020 Workplace Learning Report Pdf, Capital Fm Top 40 2020, Mya Damage Lyrics, Menthol Cigarettes Price, Consumer Reports Hot Dogs, One Word Substitution For A Sentence, The Source $25 Coupon, Chicken Pork Adobo Tuyo, Light Texture Photoshop, Sitcoms To Fall Asleep To, Delta Hotels By Marriott Woodbridge, Slow Cooker Cauliflower Curry, Seminary Faculty Jobs, Coda Di Volpe Wines, Gravity Pipe Flow Calculations Excel, Dr Berg Vital Wheat Gluten, Howard Donald Children, Miso Udon Stir Fry, Is Banana A Fruit Or Berry, And In Mips, How To Write A Manifestation List, Older Women's Tops, Mexico Population Histogram, Strozzi Palace Florence Italy, Jamie Oliver Restaurant London, Best Place To Retire In Malaysia, Coffee Mate Hazelnut Creamer Singles Calories, Coffee Shop Franchise, Vienna Porcelain Marks, Morgan Robertson Titanic Prediction, Cyber Threat Intelligence Report Pdf, Queretaro, Mexico Crime, Glenfiddich Experimental Series #01, Honne Love Me / Love Me Not Cd, Future Perfect Tense Of Eat, Ending Of Mulan 2020, Eggless Vanilla Cake With Condensed Milk, Crab Pizza With White Sauce, Is Everyone Hanging Out Without Me Review, Lilypichu First Stream, Online Marriage Canada, The Day After Summary, Flourless Keto Brownies Cream Cheese, Montana Song Lyrics, Diners, Drive-ins And Dives Recipe Book, John Abraham Instagram, Clock Tower Venice Tickets, Best Edc Knife, Ghirardelli Sauce Pump For Ghirardelli Professional Sauces, Synthesis Of Aspirin, Look Beyond The Surface, Radio Sapientia Programs, Full Size Daybed With Trundle, Toh Baat Pakki Cast, Great Value Citrus Scent Spray, Supreme Spring/summer 2020 Release Date, How To Cook Small Snails, Rough Country 30 Inch Light Bar Review, Ikea Bench Cushion, Barley Chickpea Salad, Cubic Inches To Liters, Samsung J727t Lcd, Madison Park Laurel 7-piece Comforter Set, Museum Display Cabinets, We Are Number One Singer, Yawn Meaning In Urdu, Korean Fried Chicken Burger, Cannondale Scalpel-si Carbon 4 Weight, Easy Filipino Recipes, Hero Vs Dark Knight Maplestory 2020, Maharashtra Rivers Of Karnataka, Bloom Jasmine And Rose Gin Mixer, Generalized Anxiety Disorder Symptoms, Artificial Intelligence In Finance Pdf, Spear Of The Waiting Dead, Protonation And Deprotonation Organic Chemistry, Scandinavian Vegetable Recipes, Best Breakfast In London, ,Sitemap